FPHAX vs. FBDIX
Compare and contrast key facts about Fidelity Select Pharmaceuticals Portfolio (FPHAX) and Franklin Biotechnology Discovery Fund (FBDIX).
FPHAX is managed by Fidelity. It was launched on Jun 17, 2001. FBDIX is managed by Franklin Templeton. It was launched on Sep 14, 1997.
Performance
FPHAX vs. FBDIX - Performance Comparison
Loading graphics...
FPHAX vs. FBDIX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FPHAX Fidelity Select Pharmaceuticals Portfolio | -2.56% | 30.41% | 9.39% | 12.54% | 0.94% | 11.79% | 11.16% | 31.73% | 5.41% | 10.70% |
FBDIX Franklin Biotechnology Discovery Fund | -3.29% | 52.68% | 15.37% | 18.40% | -12.65% | -27.58% | 29.85% | 49.11% | -15.77% | 18.83% |
Returns By Period
In the year-to-date period, FPHAX achieves a -2.56% return, which is significantly higher than FBDIX's -3.29% return. Over the past 10 years, FPHAX has outperformed FBDIX with an annualized return of 10.94%, while FBDIX has yielded a comparatively lower 10.22% annualized return.
FPHAX
- 1D
- 0.57%
- 1M
- -9.52%
- YTD
- -2.56%
- 6M
- 15.21%
- 1Y
- 27.23%
- 3Y*
- 16.20%
- 5Y*
- 11.88%
- 10Y*
- 10.94%
FBDIX
- 1D
- -0.30%
- 1M
- -6.49%
- YTD
- -3.29%
- 6M
- 19.63%
- 1Y
- 54.72%
- 3Y*
- 25.99%
- 5Y*
- 6.18%
- 10Y*
- 10.22%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FPHAX vs. FBDIX - Expense Ratio Comparison
FPHAX has a 0.75% expense ratio, which is lower than FBDIX's 1.06% expense ratio.
Return for Risk
FPHAX vs. FBDIX — Risk / Return Rank
FPHAX
FBDIX
FPHAX vs. FBDIX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Pharmaceuticals Portfolio (FPHAX) and Franklin Biotechnology Discovery Fund (FBDIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FPHAX | FBDIX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.14 | 1.99 | -0.85 |
Sortino ratioReturn per unit of downside risk | 1.61 | 2.59 | -0.97 |
Omega ratioGain probability vs. loss probability | 1.21 | 1.33 | -0.12 |
Calmar ratioReturn relative to maximum drawdown | 2.05 | 3.04 | -0.98 |
Martin ratioReturn relative to average drawdown | 5.99 | 12.26 | -6.27 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| FPHAX | FBDIX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.14 | 1.99 | -0.85 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.67 | 0.24 | +0.43 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.62 | 0.39 | +0.23 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.52 | 0.40 | +0.12 |
Correlation
The correlation between FPHAX and FBDIX is 0.75, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
FPHAX vs. FBDIX - Dividend Comparison
FPHAX's dividend yield for the trailing twelve months is around 5.83%, less than FBDIX's 11.18% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FPHAX Fidelity Select Pharmaceuticals Portfolio | 5.83% | 5.68% | 1.90% | 8.08% | 5.18% | 11.09% | 8.85% | 8.33% | 1.65% | 1.62% | 1.07% | 12.63% |
FBDIX Franklin Biotechnology Discovery Fund | 11.18% | 10.81% | 19.53% | 0.00% | 0.13% | 0.98% | 14.50% | 18.77% | 3.72% | 2.39% | 4.57% | 8.42% |
Drawdowns
FPHAX vs. FBDIX - Drawdown Comparison
The maximum FPHAX drawdown since its inception was -38.26%, smaller than the maximum FBDIX drawdown of -71.44%. Use the drawdown chart below to compare losses from any high point for FPHAX and FBDIX.
Loading graphics...
Drawdown Indicators
| FPHAX | FBDIX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.26% | -71.44% | +33.18% |
Max Drawdown (1Y)Largest decline over 1 year | -11.00% | -12.39% | +1.39% |
Max Drawdown (5Y)Largest decline over 5 years | -28.82% | -46.83% | +18.01% |
Max Drawdown (10Y)Largest decline over 10 years | -28.82% | -53.67% | +24.85% |
Current DrawdownCurrent decline from peak | -9.82% | -7.38% | -2.44% |
Average DrawdownAverage peak-to-trough decline | -9.21% | -28.90% | +19.69% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.35% | 3.98% | +0.37% |
Volatility
FPHAX vs. FBDIX - Volatility Comparison
The current volatility for Fidelity Select Pharmaceuticals Portfolio (FPHAX) is 6.10%, while Franklin Biotechnology Discovery Fund (FBDIX) has a volatility of 7.62%. This indicates that FPHAX experiences smaller price fluctuations and is considered to be less risky than FBDIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| FPHAX | FBDIX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.10% | 7.62% | -1.52% |
Volatility (6M)Calculated over the trailing 6-month period | 14.17% | 15.74% | -1.57% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.39% | 25.50% | -2.11% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.69% | 25.47% | -7.78% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.78% | 26.35% | -8.57% |